⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8372467 | 0.85 | PLA2G1B (0.32) | — | |
| SCHEMBL8371428 | 0.77 | CYP2C9 (0.37) | — | |
| SCHEMBL9245904 | 0.73 | PLA2G1B (0.32) | — | |
| SCHEMBL15436601 | 0.71 | HTR2A (0.30) | — | |
| SCHEMBL8040536 | 0.69 | TDP1 (0.41) | — | |
| SCHEMBL5705946 | 0.68 | CYP2C9 (0.37) | — | |
| SCHEMBL7769249 | 0.67 | TDP1 (0.36) | — | |
| SCHEMBL7682097 | 0.67 | CYP2C9 (0.34) | — | |
| SCHEMBL8663135 | 0.65 | CHRM2 (0.44) | — | |
| SCHEMBL1860605 | 0.65 | FDPS (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1734079-B1 | SINGLE-COMPONENT CURABLE COMPOSITION | KANEKA CORP (JP) | 2016-01-20 | — | — | EP | disclosed |
| EP-1930375-B1 | CURABLE COMPOSITION IMPROVED IN CURABILITY AND ADHESIVENESS | KANEKA CORP (JP) | 2012-07-04 | — | — | EP | disclosed |
| EP-1942153-B1 | CURABLE COMPOSITION IMPROVED IN CURABILITY AND STORAGE STABILITY | KANEKA CORP (JP) | 2010-11-17 | — | — | EP | disclosed |
| EP-1942153-A1 | CURABLE COMPOSITION IMPROVED IN CURABILITY AND STORAGE STABILITY | Kaneka Corporation (JP) | 2008-07-09 | — | — | EP | disclosed |
| EP-1930375-A1 | CURABLE COMPOSITION IMPROVED IN CURABILITY AND ADHESIVENESS | Kaneka Corporation (JP) | 2008-06-11 | — | — | EP | disclosed |
| US-20080021140-A1 | Curable Composition | KANEKA CORPORATION (JP) | 2008-01-24 | — | — | US | disclosed |
| US-20070208108-A1 | Single-Component Curable Composition | KANEKA CORPORATION (JP) | 2007-09-06 | — | — | US | disclosed |
| US-20070203297-A1 | Curable Composition | KANEKA CORPORATION | 2007-08-30 | — | — | US | disclosed |
| EP-1736511-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2006-12-27 | — | — | EP | disclosed |
| EP-1734079-A1 | SINGLE-COMPONENT CURABLE COMPOSITION | Kaneka Corporation (JP) | 2006-12-20 | — | — | EP | disclosed |
| EP-1731574-A1 | SINGLE-COMPONENT CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2006-12-13 | — | — | EP | disclosed |
| EP-1731573-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2006-12-13 | — | — | EP | disclosed |
| EP-0946549-A1 | COMBINATORIAL PROCESS FOR PREPARING FUSED PYRIMIDINE LIBRARIES | ELI LILLY AND COMPANY (US) | 1999-10-06 | — | — | EP | disclosed |
| WO-1998027087-A1 | COMBINATORIAL PROCESS FOR PREPARING FUSED PYRIMIDINE LIBRARIES | ELI LILLY AND COMPANY (US) | 1998-06-25 | — | — | WO | disclosed |